CEACAM3 and adenocarcinoma: First, we validated the expression of the target cell-surface glycoprotein CEA in healthy human tissue in two conventional adenocarcinoma cell lines (MKN-45 and DLD-1), as well as in patient-derived organoids from different organs (colon, rectum and small intestine) of the gastrointestinal (GI) tract.